Aptamer-grafted, cell membrane-coated dendrimer loaded with doxorubicin as a targeted nanosystem against epithelial cellular adhesion molecule (EpCAM) for triple negative breast cancer therapy-Reference-Cited by-同舟云学术

Aptamer-grafted, cell membrane-coated dendrimer loaded with doxorubicin as a targeted nanosystem against epithelial cellular adhesion molecule (EpCAM) for triple negative breast cancer therapy

Published:2023-09 Issue: Volume:86 Page:104745
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Sheikh Afsana,Abourehab Mohammed A.S.^ORCID,Tulbah Alaa S.^ORCID,Kesharwani Prashant^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference67 articles.

1. Triple-negative breast cancer therapy: current and future perspectives;Won;Int. J. Oncol.,2020

2. Nanoparticles-based drug delivery and gene therapy for breast cancer: recent advancements and future challenges;Mirza;Semin. Cancer Biol.,2021

3. Triple-negative breast cancer molecular subtyping and treatment progress;Yin;Breast Cancer Res.,2020

4. New opportunities for RGD-engineered metal nanoparticles in cancer;Qin;Mol. Cancer,2023

5. Advancements in nanoparticle-based treatment approaches for skin cancer therapy;Zeng;Mol. Cancer,2023

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamer‐Modified Tetrahedral DNA Nanostructures as Drug Delivery System for Cancer Targeted Therapy;Macromolecular Bioscience;2023-12-20

2. Hyaluronic acid engineered gallic acid embedded chitosan nanoparticle as an effective delivery system for treatment of psoriasis;Environmental Research;2023-12

3. Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches;Molecular Cancer;2023-10-06